Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development

MeSH terms

• Adolescent
• Adult
• Aged
• Biological Factors / therapeutic use*
• Clinical Trials, Phase III as Topic / methods*
• Dermatologic Agents / therapeutic use*
• Drug Discovery
• Drugs, Investigational / therapeutic use
• Humans
• Middle Aged
• Patient Selection*
• Psoriasis / drug therapy*
• Young Adult